Conference Coverage

VIDEO: Investigating the role of plasmalogens in Alzheimer’s disease


 

AT AAIC 2015

References

WASHINGTON – Could a ubiquitous lipid – manufactured in the liver – be one of the root causes of Alzheimer’s disease? Plasmalogens are important in maintaining cell membrane permeability and effective neurotransmission. They also appear to influence the production of toxic forms of amyloid-beta by affecting the activity of alpha-secretase. What are they, and how strong could their influence in Alzheimer’s be? Dayan Goodenowe, Ph.D., explains at the Alzheimer’s Association International Conference 2015.

Dr. Goodenowe is the founder and CEO of Phenomenome Discoveries, which holds patents on measuring plasmalogen levels and is developing a plasmalogen therapeutic.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

msullivan@frontlinemedcom.com

On Twitter @alz_gal

Recommended Reading

VIDEO: Consider adult ADHD in dementia differential diagnosis
MDedge Family Medicine
Oil- and nut-supplemented Mediterranean diet improves elderly cognition
MDedge Family Medicine
Androgen deprivation linked to cognitive impairment
MDedge Family Medicine
VIDEO: Stroop app predicts hepatic encephalopathy
MDedge Family Medicine
Prevalence of amyloid pathology differs across dementia type and age
MDedge Family Medicine
Hormone therapy helps mood, but not cognition, in younger menopausal women
MDedge Family Medicine
Cognitive impairment signals subclinical vascular disease
MDedge Family Medicine
Mixed pathologies are very common in black Alzheimer’s patients
MDedge Family Medicine
AAIC: Sedentary early adulthood may mean worse cognitive functioning later
MDedge Family Medicine
VIDEO: Dementia risk doubled in type 1 diabetes patients
MDedge Family Medicine